1. Stem Cells and Regenerative Medicine
Download icon

Organ Development: Tips from the embryonic lung

  1. Avinash Waghray
  2. Jayaraj Rajagopal  Is a corresponding author
  1. Harvard University, United States
Insight
  • Cited 1
  • Views 1,432
  • Annotations
Cite this article as: eLife 2017;6:e30194 doi: 10.7554/eLife.30194

Abstract

A new source of progenitor cells can now be used to study hidden aspects of human lung development and pediatric lung disease.

Main text

Most of our knowledge about the development of the lung comes from elegant experiments using mice (Hogan et al., 2014; Tata and Rajagopal, 2017). Despite the usefulness of mouse models, human and mouse lungs are distinct in many ways – including their size, the distribution of cell types, and the time they take to develop (Morrisey and Hogan, 2010; Wansleeben et al., 2013). Now, in eLife, Emma Rawlins and colleagues – including Marko Nikolić as first author – report that mouse and human embryonic lungs also express the same transcription factors in different patterns during development (Nikolić et al., 2017).

In both humans and mice, the lungs originate from a groove and a bud. The laryngotracheal groove becomes the future larynx and trachea, while the bud divides to become the origin of most of the branching airways and the gas-exchanging alveoli. Both bud and groove emerge from the primitive embryonic gut tube, whose epithelial layer is referred to as the embryonic anterior foregut endoderm (Figure 1A) since it originates from one of the three definitive germ layers of the embryo: the endoderm. As the embryonic lung develops, the epithelial cells at the tip of the embryonic lung proliferate most rapidly, dividing over and over to ultimately generate the beautiful branching structure of the adult organ.

A new method to study human embryonic lung development.

(A) The lung originates from a region of the embryonic gut, the epithelium of which is called the anterior foregut endoderm (gray shading, left tube); the numbers underneath give the age of the embryo (in days for mouse embryos and weeks for human embryos). The lung bud epithelium (gray shading, middle tube) emerges from the anterior foregut endoderm and undergoes branching morphogenesis (right tube) to give rise to stalk regions that will become the proximal airways, and a distal tip region that iteratively divides to give rise to more branching airways and eventually to alveoli (enlarged in dashed boxes). The stalk and tip regions have different expression patterns of the Sox2 and Sox9 transcription factors in humans and mice. (B) Induced pluripotent stem cells (iPSCs) can be differentiated in a stepwise fashion into definitive endoderm cells, then into anterior foregut endoderm and, finally, into airway and alveolar epithelial cells. (C) Epithelial stem cells from the airway and the alveolar compartments of the adult human lung can be manipulated in vitro to form adult airway epithelial cells (via conversion into adult basal cells) and adult alveolar organoids. (D) Nikolić et al. micro-dissected human lung bud tips and stalks (top) and analyzed them using global gene expression analysis (right) to identify signaling and transcriptional regulators that are expressed specifically in tip progenitor cells. This analysis was used to establish a chemically defined medium (CDM) in which human SOX2+SOX9+ cells self-renew over many passages. The SOX2+SOX9+ cells can be readily frozen and differentiated into airway and alveolar cell types for in vitro modeling and for engraftment experiments. Furthermore, the human SOX2-SOX9+/SOX2lowSOX9+ tips, characteristic of later developmental stages (greater than 17 weeks post-conception), and SOX2+SOX9 stalks (present at any stage of embryonic organ development before 21 weeks post-conception) convert into a SOX2+SOX9+ state in CDM cultures. This presumably reflects a reversion to an earlier tip progenitor state.

Many groups in the last decade have created in vitro models to study human embryonic lung development and lung disease. Early studies focused on the stepwise differentiation of induced pluripotent stem cells (iPSCs): iPSCs were first differentiated into endoderm cells and then into the lung progenitor cells that give rise to the various different epithelial cell types of the mature airway and the alveoli (Figure 1B; McCauley et al., 2017; Snoeck, 2015). Other approaches have focused on generating an expandable source of adult airway and alveolar cells directly from adult tissues (Figure 1C; Gotoh et al., 2014; Mou et al., 2016).

In humans, for obvious reasons, it has been impossible to dissect the mechanisms that underlie how lungs and other organs develop in embryos. However, we know that in mice, the transcription factor Sox2 is essential for the initiation of lung development from the gut tube, and is later expressed exclusively in the epithelial cells of the ‘stalk’ that in turn give rise to the epithelium of the airway. By contrast, tip epithelial cells express a related transcription factor, Sox9, that is necessary for the maintenance of tip cells themselves (Hogan et al., 2014; Rockich et al., 2013).

By generating an alternate and renewable source of progenitor cells from the human embryonic lung, Nikolić et al. – who are based at the University of Cambridge and University College London – now demonstrate that, unlike in the mouse, human embryonic lung tip cells produce both SOX2 and SOX9. After dissecting human embryonic tips and stalks, global gene expression analysis of the epithelium was used to identify genes specific to each cell type. By determining which growth factor-related genes were present in each of these cells, Nikolić et al. fashioned a chemically defined medium to grow tip cells as organoids. They were further able to expand, freeze and differentiate these tip-derived cells (Figure 1D).

Interestingly, the human stalk epithelial cells that produced SOX2 but did not produce SOX9 showed remarkable plasticity, and were able to give rise to “SOX2+SOX9+” tip progenitor cells. This plasticity harkens back to a classical finding from experiments performed on mice, in which tip mesenchyme cells (these are cells adjacent to the tip epithelial cells that presumably serve as a source of the growth factors that are necessary to maintain the epithelial tip cells) were grafted onto the tracheal epithelium. This grafting resulted in the formation of buds on the trachea which then started branching (Alescio and Cassini, 1962) and this phenomenon was later shown to reflect the conversion of Sox2+ tracheal epithelial cells into Sox9+ bud cells (Hogan et al., 2014). This, however, only occurred during the very early stages of lung development. Perhaps, under the right conditions, early and late stage mouse stalk cells could exhibit plasticity that mirrors the findings of Nikolić et al. in the human case, but perhaps not.

Notably, the cultured human SOX2+SOX9+ tip cells differentiate into both airway and alveolar cells when grown in vitro or in mice. Whether the differentiated cells fully mature and become fully functional remains to be seen, but the results are promising.

The hitherto unknown facets of human embryonic lung development that Nikolić et al. reveal can now be mechanistically scrutinized. The human SOX2+SOX9+ cells they cultured could potentially be used to model pediatric lung diseases (such as bronchopulmonary dysplasia), which are thought to originate during lung development. Indeed, because human SOX2+SOX9+ cells are derived from embryonic lungs, they are likely to more faithfully reflect the epigenetic features of the embryonic cells that contribute to pediatric lung disease than cells derived from adult lung epithelial cells or iPSCs. For example, iPSC-derived lung cells could possess abnormal epigenetic marks and/or the epigenetic and genetic state of cells derived from adult lungs may reflect environmental assaults encountered in the course of adulthood that are not relevant for fetal and postnatal lung disease. Thus the availability of embryonic lung epithelial cells is likely to open up whole new fields of important inquiry.

References

Article and author information

Author details

  1. Avinash Waghray

    Avinash Waghray is at Massachusetts General Hospital, Harvard University, Boston, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3242-2227
  2. Jayaraj Rajagopal

    Jayaraj Rajagopal is at Massachusetts General Hospital, Harvard University, Boston, United States

    For correspondence
    JRAJAGOPAL@mgh.harvard.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4122-177X

Acknowledgements

We would like to acknowledge Vladimir Vinarsky, Lujia Yang and Aleksander D Szymaniak for editing the manuscript and helpful discussions.

Publication history

  1. Version of Record published: August 14, 2017 (version 1)

Copyright

© 2017, Waghray et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,432
    Page views
  • 245
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Stem Cells and Regenerative Medicine
    Francis Grafton et al.
    Research Article

    Drug-induced cardiotoxicity and hepatotoxicity are major causes of drug attrition. To decrease late-stage drug attrition, pharmaceutical and biotechnology industries need to establish biologically relevant models that use phenotypic screening to detect drug-induced toxicity in vitro. In this study, we sought to rapidly detect patterns of cardiotoxicity using high-content image analysis with deep learning and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). We screened a library of 1280 bioactive compounds and identified those with potential cardiotoxic liabilities in iPSC-CMs using a single-parameter score based on deep learning. Compounds demonstrating cardiotoxicity in iPSC-CMs included DNA intercalators, ion channel blockers, epidermal growth factor receptor, cyclin-dependent kinase, and multi-kinase inhibitors. We also screened a diverse library of molecules with unknown targets and identified chemical frameworks that show cardiotoxic signal in iPSC-CMs. By using this screening approach during target discovery and lead optimization, we can de-risk early-stage drug discovery. We show that the broad applicability of combining deep learning with iPSC technology is an effective way to interrogate cellular phenotypes and identify drugs that may protect against diseased phenotypes and deleterious mutations.

    1. Stem Cells and Regenerative Medicine
    Jacqueline Larouche et al.
    Research Article

    During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function impacting mobility and quality of life. Muscle loss is often associated with denervation and a loss of resident muscle stem cells (satellite cells or MuSCs), however, the relationship between MuSCs and innervation has not been established. Herein, we administered severe neuromuscular trauma to a transgenic murine model that permits MuSC lineage tracing. We show that a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ), the synapse between myofibers and motor neurons, in healthy young adult muscles. In aging and in a mouse model of neuromuscular degeneration (Cu/Zn superoxide dismutase knockout – Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ in a manner akin to young muscle and partially restored MuSC ability to engraft into positions proximal to the NMJ. Using single cell RNA-sequencing of MuSCs isolated from aged muscle, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury and share similarity to synaptic myonuclei. Collectively, these data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors.